UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001985
Receipt number R000002295
Scientific Title Comparison of the rate of diagnosis and fluoroscopy time in lung cancer in groups before and after Endobronchial ultrasonography (EBUS) introduction
Date of disclosure of the study information 2009/05/25
Last modified on 2010/08/02 19:04:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of the rate of diagnosis and fluoroscopy time in lung cancer in groups before and after Endobronchial ultrasonography (EBUS) introduction

Acronym

Comparison of the rate of diagnosis and fluoroscopy time in lung cancer in groups before and after Endobronchial ultrasonography (EBUS) introduction

Scientific Title

Comparison of the rate of diagnosis and fluoroscopy time in lung cancer in groups before and after Endobronchial ultrasonography (EBUS) introduction

Scientific Title:Acronym

Comparison of the rate of diagnosis and fluoroscopy time in lung cancer in groups before and after Endobronchial ultrasonography (EBUS) introduction

Region

Japan


Condition

Condition

lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Endobronchial ultrasonography (EBUS) has been used in diagnosing peripheral lung cancer and has allowed for higher rates of peripheral lung cancer diagnosis, but few studies have reported that fluoroscopy time is shorted by the use of EBUS. Therefore, this study is a
retrospective study on shorting fluoroscopy time using EBUS.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of the rate of diagnosis and fluoroscopy time in lung cancer in groups before and after EBUS introduction

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Discussion of the rate of diagnosis and fluoroscopy time in lung cancer in groups before EBUS introduction during twenty-one months

Interventions/Control_2

Comparison of the rate of diagnosis and fluoroscopy time in lung cancer in groups after EBUS introduction during twenty-one months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Cases diagnosed as lung cancer by bronchoscope

Key exclusion criteria

Cases judged that method of bronchoscope is difficult



Target sample size

180


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshitsugu Fujita

Organization

St Marianna University school of Medicine

Division name

Division of Respiratory and Infectious Diseases Department of Internal Medicine

Zip code


Address

2-16-1 Sugao Miyamaeku Kawasaki Kanagawa Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

St Marianna University school of Medicine

Division name

Division of Respiratory and Infectious Diseases Department of Internal Medicine

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

St Marianna University school of Medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 05 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 01 Month 16 Day

Date of IRB


Anticipated trial start date

2009 Year 02 Month 01 Day

Last follow-up date

2014 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 05 Month 19 Day

Last modified on

2010 Year 08 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002295


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name